Carol Kobrin

Medicine & Life Sciences

1. Lymphoma 100%
2. Vaccines 91%
3. Cancer Vaccines 80%
4. T-Lymphocytes 79%
5. Follicular Lymphoma 78%
6. B-Lymphocytes 56%
7. Neoplasm Antigens 53%
8. Immunoglobulin Heavy Chains 48%
9. Epitopes 47%
10. Neoplasms 45%
11. Germinal Center 43%
12. Complementarity Determining Regions 38%
13. Mantle-Cell Lymphoma 36%
14. Immunoglobulin Genes 35%
15. Gene Rearrangement 32%
16. Immunity 30%
17. Active Immunotherapy 30%
18. Granulocyte Colony-Stimulating Factor 29%
19. Vaccination 28%
20. Precursor Cell Lymphoblastic Leukemia-Lymphoma 27%
21. Antigens 27%
22. Immunodominant Epitopes 24%
23. Monocytes 22%
24. Antibody Formation 20%
25. Light 19%
26. Immunoglobulin Light Chains 19%
27. Non-Hodgkin's Lymphoma 17%
28. Colonic Neoplasms 16%
29. RAG-1 Genes 15%
30. Melanoma 15%
31. Nucleotides 14%
32. Residual Neoplasm 14%
33. Gene Expression 13%
34. Vaccine Potency 13%
35. Immunoglobulins 12%
36. Adoptive Immunotherapy 12%
37. Drug Therapy 12%
38. Microdissection 11%
39. Subunit Vaccines 11%
40. T-Lymphocyte Epitopes 11%
41. Clone Cells 11%
42. Clinical Trials 10%
43. Germ-Line Mutation 10%
44. Sequence Homology 10%
45. Antigen Presentation 10%
46. Cytokines 9%
47. Mutation 9%
48. Genetic Recombination 8%
49. Proteins 8%
50. Polymerase Chain Reaction 8%